Aline Lima Nogare
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Aline Lima Nogare has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Francisco Veríssimo Veronese
Laboratory of Molecular Biology Applied to Nephrology, Experimental Research Center, Hospital de Clínicas de Porto Alegre, 90035-903 Porto Alegre, Brazil
1 shared publication - Jose Alberto Pedroso
Renal Transplant Unit, Organ Transplant Ph.D. Program, Policlinico Agostino Gemelli, Università Cattolica del Sacro Cuore, Rome, Italy
1 shared publication - Karla Lais Pêgas
Division of Pathology, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
1 shared publication - Luiz Felipe Gonçalves
Post-Graduate Medical Sciences Program, School of Medicine, Federal University of Rio Grande do Sul, Porto Alegre, Brazil
1 shared publication - Roberto Ceratti Manfro
Post-Graduate Medical Sciences Program, School of Medicine, Federal University of Rio Grande do Sul, Porto Alegre, Brazil
1 shared publication - Rosangela Munhoz Montenegro
Hospital de Clínicas de Porto Alegre, Brazil
1 shared publication
Latest Publications
- Open Access
- 13 February 2015
- Published by Springer Nature in BMC Nephrology
- Vol. 16 (1) , 19
Kidney injury molecule-1 expression in human kidney transplants with interstitial fibrosis and tubular atrophy
Kidney injury molecule-1 (KIM-1) is expressed in tubular epithelial cells after injury and may have a role in the development of renal graft fibrosis. In this study we evaluated the molecular and protein expressions of KIM-1 in dysfunctional allografts and also mRNA KIM-1 expression in urine as potential biomarkers of graft fibrosis. Protein and mRNA levels in renal tissue and urinary sediment cells of 69 kidney transplant recipients that undertook for-cause graft biopsies were evaluated by immunohistochemistry and real-time polymerase chain reaction. The histopathology was classified according to the 2007 Banff schema. KIM-1 protein expression was increased in biopsies with interstitial fibrosis and tubular atrophy (IF/TA) compared with biopsies showing acute calcineurin inhibitor nephrotoxicity (CIN) (P <0.05). Kidney tissue KIM-1 mRNA signaling (in) was increased in biopsies with IF/TA compared with all other groups (P <0.05). In the urine cells KIM-1 mRNA was also increased in patients with IF/TA compared with patients with acute CIN (P <0.05). Significant correlations were found between KIM-1 protein and mRNA levels in tissue, between mRNA expressions in tissue and urine and between protein tissue expression and gene expression in the urine. KIM-1 seems to be a marker of kidney graft fibrosis. Urinary KIM-1 mRNA may become a useful non-invasive biomarker of the injuries that can trigger intra-graft fibrotic processes, such as interstitial fibrosis and tubular atrophy.
- 13 February 2015
- Published by Springer Nature in BMC Nephrology
- Vol. 16 (1) , 19
Open AccessKidney injury molecule-1 expression in human kidney transplants with interstitial fibrosis and tubular atrophy
Kidney injury molecule-1 (KIM-1) is expressed in tubular epithelial cells after injury and may have a role in the development of renal graft fibrosis. In this study we evaluated the molecular and protein expressions of KIM-1 in dysfunctional allografts and also mRNA KIM-1 expression in urine as potential biomarkers of graft fibrosis. Protein and mRNA levels in renal tissue and urinary sediment cells of 69 kidney transplant recipients that undertook for-cause graft biopsies were evaluated by immunohistochemistry and real-time polymerase chain reaction. The histopathology was classified according to the 2007 Banff schema. KIM-1 protein expression was increased in biopsies with interstitial fibrosis and tubular atrophy (IF/TA) compared with biopsies showing acute calcineurin inhibitor nephrotoxicity (CIN) (P <0.05). Kidney tissue KIM-1 mRNA signaling (in) was increased in biopsies with IF/TA compared with all other groups (P <0.05). In the urine cells KIM-1 mRNA was also increased in patients with IF/TA compared with patients with acute CIN (P <0.05). Significant correlations were found between KIM-1 protein and mRNA levels in tissue, between mRNA expressions in tissue and urine and between protein tissue expression and gene expression in the urine. KIM-1 seems to be a marker of kidney graft fibrosis. Urinary KIM-1 mRNA may become a useful non-invasive biomarker of the injuries that can trigger intra-graft fibrotic processes, such as interstitial fibrosis and tubular atrophy.